1954P ctDNA analysis in phase III SACHI trial: Savolitinib (savo) plus osimertinib (osi) versus chemotherapy (chemo) in MET-amplified (METamp) advanced NSCLC after disease progression (PD) on EGFR tyrosine kinase inhibitor (TKI)
Year: 2025
Type: article
Source: Annals of Oncology
Institutions: Shanghai Jiao Tong University, Shanghai Chest Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, HUTCHMED (China) Limited (China), Hunan Cancer Hospital, First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Henan Cancer Hospital, First Affiliated Hospital of Nanchang University, ShenZhen People’s Hospital, Fujian Provincial Cancer Hospital, The First Affiliated Hospital, Sun Yat-sen University, First Hospital of China Medical University, Xiangyang Central Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4415940586
